Medication info
Aldemax Plus D Tablet

Aldemax Plus D Tablet

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Trihydrate›91.37mg / 1 tabletCholecalciferol Concentrate Powder›53.33mg / 1 tablet
Manufacturer / importer
CTC Bio, Co., Ltd.
Appearance
White to grayish rectangular tablets
Packaging
4 tablets / PTP packaging
Approval status
Active

MFDS item code 201603802 · Approved 2016.06.23 · Insurance code 669502060

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see General Precautions). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuation after 3~5 years of treatment should be considered. Patients who discontinue treatment should be regularly reassessed for fracture risk. Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see Interactions). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce its absorption into the body and decrease its effect. This medicine should be taken immediately after getting up in the morning, swallowed with plenty of water (170∼230 mL) to deliver the medicine rapidly to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and General Precautions). Patients with inadequate calcium and vitamin D intake from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic disease) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplementation, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides a one-week supply of 400 IU or 800 IU of vitamin D per day. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Administration to elderly patients (65 years and older): No dose adjustment is necessary. Administration to patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min). However, because clinical experience in patients with severe renal impairment (creatinine clearance below 35 mL/min) is insufficient, administration of this medicine is not recommended.
Child dose
Children and adolescents (under 18 years of age): Safety and efficacy in children and adolescents have not been established.

Ingredients

Manufacturer
CTC Bio, Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medicine is used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see General Precautions). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuation after 3~5 years of treatment should be considered. Patients who discontinue treatment should be regularly reassessed for fracture risk. Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see Interactions). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce its absorption into the body and decrease its effect. This medicine should be taken immediately after getting up in the morning, swallowed with plenty of water (170∼230 mL) to deliver the medicine rapidly to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and General Precautions). Patients with inadequate calcium and vitamin D intake from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic disease) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplementation, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides a one-week supply of 400 IU or 800 IU of vitamin D per day. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Administration to elderly patients (65 years and older): No dose adjustment is necessary. Administration to patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min). However, because clinical experience in patients with severe renal impairment (creatinine clearance below 35 mL/min) is insufficient, administration of this medicine is not recommended.

Child dose

Children and adolescents (under 18 years of age): Safety and efficacy in children and adolescents have not been established.

Precautions

This medicine may irritate the upper gastrointestinal mucosa, potentially leading to adverse esophageal reactions such as esophagitis, esophageal ulcers, and esophageal erosion. If symptoms of esophageal irritation occur, discontinue use immediately and consult a physician. Take the medicine with a sufficient amount of water, and do not lie down for 30 minutes after taking it. Caution is necessary for patients with upper gastrointestinal diseases such as esophageal disorders, gastritis, duodenitis, and ulcers. This medicine should not be given to patients with esophageal stricture or achalasia, patients who cannot sit upright or stand for more than 30 minutes, patients with hypersensitivity to the ingredients, or patients with hypocalcemia. Taking this medicine may result in adverse reactions such as abdominal pain, nausea, dyspepsia, constipation, diarrhea, acid reflux, esophagitis, musculoskeletal pain, headache, dizziness, and rash. Particularly, with long-term use, rare occurrences of jaw osteonecrosis, severe bone pain, and severe skin reactions may occur, so any unusual symptoms should be immediately reported to a physician. This medicine may interfere with absorption when taken with calcium supplements or antacids, so it is recommended to space the administration by at least 30 minutes. Additionally, caution is needed as the risk of gastrointestinal adverse reactions may increase when taken with aspirin or non-steroidal anti-inflammatory drugs. During pregnancy, the benefits and risks to the mother and fetus should be carefully considered before administration, and caution is also necessary during breastfeeding. Not for use in children. Elderly patients or those with significantly impaired renal function should follow the physician's instructions regarding dose adjustments or administration. Take the medicine with a sufficient amount of water at least 30 minutes before meals, and do not lie down after taking it or chew or suck on it. Store this medicine in a tightly sealed container to prevent exposure to air or moisture. It is also advisable to keep it in a dark place, away from direct light, and maintain a temperature between 1°C and 30°C.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, dysphagia, odynophagia, pain behind the sternum, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle spasms, headache, dizziness, taste disturbances, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oral-pharyngeal ulcer, gastric ulcer, duodenal ulcer, osteomyelitis, jaw necrosis, joint swelling, low-energy fractures of the femoral head and other bones, dizziness, vertigo, pruritus, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, nasopharyngitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture. It is also advisable to keep it at room temperature between 1°C and 30°C, in a dark place away from direct light.

Appearance and packaging

Appearance

White to grayish rectangular tablets

Package unit

4 tablets / PTP packaging

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.